Multi-parametric magnetic resonance imaging (mpMRI) of the prostate gland has been a proven imaging test to help improve the accuracy of the PSA blood test in diagnosing prostate cancer.

Many large clinical trials in the U.S. and around the world* have demonstrated its proven benefit in reducing the number of unnecessary invasive prostate biopsies and in improving the detection of cancer by navigating the direction of the needle biopsy samples.

Many areas in the U.S., England and Europe routinely perform prostate MRI with the PSA blood test prior to any prostate biopsy to better assess an individual’s risk for prostate cancer. A large Ontario study demonstrated that complications, particularly serious infection, from prostate biopsies** are on the rise. The use of prostate MRI with the PSA can reduce the need for unnecessary, invasive prostate biopsies.

The Ministry of Health and Long Term Care of Ontario does not fund the use of prostate MRI for prostate cancer screening (that is prior to a prostate biopsy) for Ontarians. In another words, physicians cannot offer prostate MRI for men with an elevated PSA who has not had a prior biopsy under OHIP.

TAKE YOUR CONCERNS INTO YOUR OWN HANDS

Prostate MRI for prostate cancer screening is available in Ontario from MRI centres as a non-insured, non-OHIP service. You can arrange a prostate MRI from prostaterisk.ca.

* N Engl J Med. 2018 May 10;378(19):1767-1777.
** J Urol. 2010 Mar;183(3):963-8.